UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

vigiGrade: A Tool to Identify Well-Documented Individual Case Reports and Highlight Systematic Data Quality Issues

Drug safety, 2014, Vol.37 (1), p.65-77

2014

Volltextzugriff (PDF)

Shrinkage observed-to-expected ratios for robust and transparent large-scale pattern discovery

Statistical methods in medical research, 2013-02, Vol.22 (1), p.57-69

2013

Volltextzugriff (PDF)

Improved Statistical Signal Detection in Pharmacovigilance by Combining Multiple Strength-of-Evidence Aspects in vigiRank: Retrospective Evaluation against Emerging Safety Signals

Drug safety, 2014-08, Vol.37 (8), p.617-628

2014

Volltextzugriff (PDF)

Pneumonia may be more frequent and have more fatal outcomes with clozapine than with other second‐generation antipsychotics

World psychiatry, 2020-02, Vol.19 (1), p.120-121

2020

Volltextzugriff (PDF)

Good Signal Detection Practices: Evidence from IMI PROTECT

Drug safety, 2016-06, Vol.39 (6), p.469-490

2016

Volltextzugriff (PDF)

Risk Factor Considerations in Statistical Signal Detection: Using Subgroup Disproportionality to Uncover Risk Groups for Adverse Drug Reactions in VigiBase

Drug safety, 2020-10, Vol.43 (10), p.999-1009

2020

Volltextzugriff (PDF)

vigiRank for statistical signal detection in pharmacovigilance: First results from prospective real‐world use

Pharmacoepidemiology and drug safety, 2017-08, Vol.26 (8), p.1006-1010

2017

Volltextzugriff (PDF)

A method for data‐driven exploration to pinpoint key features in medical data and facilitate expert review

Pharmacoepidemiology and drug safety, 2017-10, Vol.26 (10), p.1256-1265

2017

Volltextzugriff (PDF)

Current Safety Concerns with Human Papillomavirus Vaccine: A Cluster Analysis of Reports in VigiBase

Drug safety, 2017-01, Vol.40 (1), p.81-90

2017

Volltextzugriff (PDF)

Performance of Probabilistic Method to Detect Duplicate Individual Case Safety Reports

Drug safety, 2014-04, Vol.37 (4), p.249-258

2014

Volltextzugriff (PDF)

The REporting of A Disproportionality Analysis for DrUg Safety Signal Detection Using Individual Case Safety Reports in PharmacoVigilance (READUS-PV): Explanation and Elaboration

Drug safety, 2024-06, Vol.47 (6), p.585-599

2024

Volltextzugriff (PDF)

Assessment of the Utility of Social Media for Broad-Ranging Statistical Signal Detection in Pharmacovigilance: Results from the WEB-RADR Project

Drug safety, 2018-12, Vol.41 (12), p.1355-1369

2018

Volltextzugriff (PDF)

The Development and Evaluation of Triage Algorithms for Early Discovery of Adverse Drug Interactions

Drug safety, 2013-05, Vol.36 (5), p.371-388

2013

Volltextzugriff (PDF)

Signals of Adverse Drug Reactions Communicated by Pharmacovigilance Stakeholders: A Scoping Review of the Global Literature

Drug safety, 2023-02, Vol.46 (2), p.109-120

2023

Volltextzugriff (PDF)

Zoo or Savannah? Choice of Training Ground for Evidence-Based Pharmacovigilance

Drug safety, 2014-09, Vol.37 (9), p.655-659

2014

Volltextzugriff (PDF)

Temporal pattern discovery in longitudinal electronic patient records

Data mining and knowledge discovery, 2010-05, Vol.20 (3), p.361-387

2010

Volltextzugriff (PDF)

Performance of Stratified and Subgrouped Disproportionality Analyses in Spontaneous Databases

Drug safety, 2016-04, Vol.39 (4), p.355-364

2016

Volltextzugriff (PDF)

A Comparison of Signals of Designated Medical Events and Non-designated Medical Events: Results from a Scoping Review

Drug safety, 2024-05, Vol.47 (5), p.475-485

2024

Volltextzugriff (PDF)

Data-Driven Identification of Adverse Event Reporting Patterns for Japan in VigiBase, the WHO Global Database of Individual Case Safety Reports

Drug safety, 2019-12, Vol.42 (12), p.1487-1498

2019

Volltextzugriff (PDF)

Interstitial Lung Disease as an Adverse Drug Reaction in Japan: Exploration of Regulatory Actions as a Basis for High Reporting

Drug safety, 2020-11, Vol.43 (11), p.1121-1131

2020

Volltextzugriff (PDF)

The Power of the Case Narrative - Can it be Brought to Bear on Duplicate Detection?

Drug safety, 2017-07, Vol.40 (7), p.543-546

Norén, G. Niklas

2017

Volltextzugriff (PDF)

Pharmacovigilance for a Revolving World: Prospects of Patient-Generated Data on the Internet

Drug safety, 2014-10, Vol.37 (10), p.761-764

Noren, G Niklas

2014

Volltextzugriff (PDF)

Consensus clustering for case series identification and adverse event profiles in pharmacovigilance

Artificial intelligence in medicine, 2021-12, Vol.122, p.102199, Article 102199

2021

Volltextzugriff (PDF)

Empirical Performance of the Calibrated Self-Controlled Cohort Analysis Within Temporal Pattern Discovery: Lessons for Developing a Risk Identification and Analysis System

Drug safety, 2013-10, Vol.36 (Suppl 1), p.107-121

2013

Volltextzugriff (PDF)

Post-Marketing Safety Profile of Vortioxetine Using a Cluster Analysis and a Disproportionality Analysis of Global Adverse Event Reports

Drug safety, 2022-02, Vol.45 (2), p.145-153

2022

Volltextzugriff (PDF)

1 – 25 von 724

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(643)
Mit Volltextzugriff
(572)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

4 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

vigiGrade: A Tool to Identify Well-Documented Individual Case Reports and Highlight Systematic Data Quality Issues

Shrinkage observed-to-expected ratios for robust and transparent large-scale pattern discovery

Improved Statistical Signal Detection in Pharmacovigilance by Combining Multiple Strength-of-Evidence Aspects in vigiRank: Retrospective Evaluation against Emerging Safety Signals

Pneumonia may be more frequent and have more fatal outcomes with clozapine than with other second‐generation antipsychotics

Good Signal Detection Practices: Evidence from IMI PROTECT

Risk Factor Considerations in Statistical Signal Detection: Using Subgroup Disproportionality to Uncover Risk Groups for Adverse Drug Reactions in VigiBase

vigiRank for statistical signal detection in pharmacovigilance: First results from prospective real‐world use

A method for data‐driven exploration to pinpoint key features in medical data and facilitate expert review

Current Safety Concerns with Human Papillomavirus Vaccine: A Cluster Analysis of Reports in VigiBase

Performance of Probabilistic Method to Detect Duplicate Individual Case Safety Reports

The REporting of A Disproportionality Analysis for DrUg Safety Signal Detection Using Individual Case Safety Reports in PharmacoVigilance (READUS-PV): Explanation and Elaboration

Assessment of the Utility of Social Media for Broad-Ranging Statistical Signal Detection in Pharmacovigilance: Results from the WEB-RADR Project

The Development and Evaluation of Triage Algorithms for Early Discovery of Adverse Drug Interactions

Signals of Adverse Drug Reactions Communicated by Pharmacovigilance Stakeholders: A Scoping Review of the Global Literature

Zoo or Savannah? Choice of Training Ground for Evidence-Based Pharmacovigilance

Temporal pattern discovery in longitudinal electronic patient records

Performance of Stratified and Subgrouped Disproportionality Analyses in Spontaneous Databases

A Comparison of Signals of Designated Medical Events and Non-designated Medical Events: Results from a Scoping Review

Data-Driven Identification of Adverse Event Reporting Patterns for Japan in VigiBase, the WHO Global Database of Individual Case Safety Reports

Interstitial Lung Disease as an Adverse Drug Reaction in Japan: Exploration of Regulatory Actions as a Basis for High Reporting

The Power of the Case Narrative - Can it be Brought to Bear on Duplicate Detection?

Pharmacovigilance for a Revolving World: Prospects of Patient-Generated Data on the Internet

Consensus clustering for case series identification and adverse event profiles in pharmacovigilance

Empirical Performance of the Calibrated Self-Controlled Cohort Analysis Within Temporal Pattern Discovery: Lessons for Developing a Risk Identification and Analysis System

Post-Marketing Safety Profile of Vortioxetine Using a Cluster Analysis and a Disproportionality Analysis of Global Adverse Event Reports

Suchergebnisse filtern